Literature DB >> 8880194

Clinical presentation and natural history of AIDS--related Kaposi's sarcoma.

B J Dezube1.   

Abstract

The clinical course of KS is highly variable, ranging from minimal disease to explosive growth. Extracutaneous spread is common, involving most frequently the oral cavity, GI tract, lungs, and lymph nodes. Both corticosteroid therapy and opportunistic infections are associated with the development of KS and with exacerbation of pre-existing KS in HIV-infected patients. A typical initial evaluation includes a thorough physical examination, fecal occult blood test, chest roentgenogram, and CD4+ T-lymphocyte count. The staging system most commonly used groups patients according to extent of tumor, immune status, and severity of systemic illness. After adjusting for prognostic factors, the most important of which is the median CD4+ T-lymphocyte count at presentation the survival of patients with KS is improving as the AIDS epidemic matures.

Entities:  

Mesh:

Year:  1996        PMID: 8880194     DOI: 10.1016/s0889-8588(05)70382-8

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  21 in total

1.  Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi's sarcoma.

Authors:  Dong Ta Zhong; Chun Mei Shi; Qiang Chen; Jing Ze Huang; Jian Gang Liang; Dong Lin
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-11       Impact factor: 4.553

2.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

Review 3.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

Review 4.  Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview.

Authors:  Narayanan Sathish; Yan Yuan
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

5.  A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.

Authors:  Henry H Chang; Don Ganem
Journal:  Cell Host Microbe       Date:  2013-04-17       Impact factor: 21.023

6.  Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.

Authors:  Alexandre Mercier; Carolina Arias; Alexis S Madrid; Meghan M Holdorf; Don Ganem
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

7.  Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.

Authors:  Fahad Mukhtar; Mmadili Ilozumba; Ovie Utuama; Oguz Cimenler
Journal:  JAMA Oncol       Date:  2018-01-01       Impact factor: 31.777

8.  Morgellons disease: Analysis of a population with clinically confirmed microscopic subcutaneous fibers of unknown etiology.

Authors:  Virginia R Savely; Raphael B Stricker
Journal:  Clin Cosmet Investig Dermatol       Date:  2010-05-13

9.  False-Negative Results of Endoscopic Biopsy in the Diagnosis of Gastrointestinal Kaposi's Sarcoma in HIV-Infected Patients.

Authors:  Naoyoshi Nagata; Katsunori Sekine; Toru Igari; Yohei Hamada; Hirohisa Yazaki; Norio Ohmagari; Junichi Akiyama; Takuro Shimbo; Katsuji Teruya; Shinichi Oka; Naomi Uemura
Journal:  Patholog Res Int       Date:  2012-11-26

10.  Predictive clinical factors in the diagnosis of gastrointestinal Kaposi's sarcoma and its endoscopic severity.

Authors:  Naoyoshi Nagata; Takuro Shimbo; Hirohisa Yazaki; Naoki Asayama; Junichi Akiyama; Katsuji Teruya; Toru Igari; Norio Ohmagari; Shinichi Oka; Naomi Uemura
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.